metabolex ppar 2008 Pages on BioPortfolio:

BioPortfolio - Metabolex Incorporated - Profile
Research and Preclinical Development, Metabolex, Inc., 3876 Bay Center- PPAR Res . 2008;2008:465715. (DOI Direct Link). • PPARS and Obesity. ...
http://www.bioportfolio.com/biocorporate/6981-Metabolex+Inco...

Biotechnology and Pharmaceutical Industry Search Find Companies ...
Metabasis Therapeutics Announces Third Quarter 2008 Results and Recent ... Metabolex Announces Positive Results From Phase 1a Clinical Trial of MBX-2982
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Metabolex Incorporated - Profile
Selective Modulators of PPAR-gamma Activity: Molecular Aspects Related to Obesity and ... KOTA Territory News: Sep 10 2008 12:40AM Matching: metabolex ...
http://www.bioportfolio.com/biocorporate/6981-Metabolex%2BIn...

BioPortfolio - Metabolex, Inc. - Profile
Rehab Manegement: Nov 4 2008 12:42AM Matching: metabolex inc ... 7323480- Substituted triazoles as modulators of PPAR and methods of their preparation ...
http://www.bioportfolio.com/biocorporate/26429-Metabolex,%2B...

BioPortfolio - Metabolex, Inc. - Profile
Pharma Live: Oct 3 2008 8:43AM Matching: metabolex inc ... 7323480- Substituted triazoles as modulators of PPAR and methods of their preparation ...
http://www.bioportfolio.com/biocorporate/26429-Metabolex,+In...

Cardiovascular safety determines the direction of PPAR agonist R&D
Clinical data with improved modulators of PPAR gamma from Metabolex indicate that this side effect can be avoided. While two other PPAR gamma agonist ...
http://www.bioportfolio.com/biotech_news/lamerie_7.htm...

BioPortfolio - Weight Gain
2008 Nov 7. DOI Direct Link · Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, ...
http://www.bioportfolio.com/indepth/Weight_Gain.html...

BioPortfolio - calyx pharmaceutical
9.3.10.3 CLX-0921 (Calyx Pharmaceuticals) 9.3.10.4 Metaglidasen (Metabolex) 9.3. 10.5 AMG 131 (Amgen) 9.3.11 New PPAR agonist combinations . ...
http://www.bioportfolio.com/search/calyx_pharmaceutical.html...

Competitor Analysis: Emerging Diabetes Drugs
Global Antivirals Market Analysis & Forecasts 2008-2023 ... treatment modalities for type 1 and 2 diabetes beyond the established targets PPAR agonists, ...
http://www.bioportfolio.com/cgi-bin/acatalog/Competitor_Anal...

Results from other life science and pharmaceutical sites:

Metabolex, Inc. Enters Into A Comprehensive Development And ...
In addition, as part of the transaction, Metabolex gains exclusive license to a PPAR-delta agonist program, including RWJ-800025, which has completed Phase ...
http://www.biospace.com/news_story.aspx?NewsEntityId=22739...

...

Cross-Species Differential Plasma Protein Binding ...[PPAR Res ...
Research and Preclinical Development, Metabolex, Inc., 3876 Bay Center Place, ... 2008]; Binding of gefitinib, an inhibitor of epidermal growth factor ...
http://www.ncbi.nlm.nih.gov/pubmed/18815616...

Two Metabolex Projects Recognized in Windhover's Top 10 Lists for ...
Metabolex plans to present information on MBX-2982 and MBX-8025 on November 4, 2008 at Windhover's Therapeutic Area Partnerships conference in Philadelphia,
...
http://biz.yahoo.com/prnews/081103/aqm036.html?.v=68...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.